| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.04 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.05 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.058 | 0.05 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.088 | 0.05 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.063 | 0.05 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.094 | 0.05 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.05 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.05 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | 0.066 | 0.05 |
| mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | 0.065 | 0.05 |